People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SMSbiotech, Inc. | — | Biotechnology | Series B | $15.8M | $64.6M | 2025 |
| Neuroptics Inc | — | Other Health Care | Seed | $2.2M | $12.4M | 2011 |
Joseph Kiani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Joseph Kiani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Worthen | 1 | 2 |
| Kamran Siminou | 1 | 1 |
| Willam Worthen | 1 | 1 |
| Deborah Siminou | 1 | 1 |
| Lawrence Marshall | 1 | 1 |
| Harry Friedman | 1 | 1 |
| Ghassan Kassab | 1 | 1 |
| Mohamed Diab | 1 | 1 |
| Abdulkader Rahmo, Ph.D. | 1 | 1 |
| Bob Mellen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.